Why Normal-Weight People Get Gout: The Visceral Fat Your BMI Can’t See
New EULAR 2026 MRI research shows visceral fat, liver fat, and muscle fat drive gout risk even in normal-weight people. Here is what BMI misses and what you can do about it.
New EULAR 2026 MRI research shows visceral fat, liver fat, and muscle fat drive gout risk even in normal-weight people. Here is what BMI misses and what you can do about it.
A new study of 94,759 patients found only 12.4% hit their uric acid target. Here are the five real reasons your gout medication isn’t working and what to do about it.
Chugging protein shakes and eating 200g of protein a day? It might be raising your uric acid. Here’s what the latest research says about proteinmaxxing and gout risk in young, active men.
NASP, a monthly intravenous infusion combining nanoencapsulated sirolimus and pegadricase, produced complete tophus resolution in up to 70 percent of uncontrolled gout patients in phase 3 trials. Here is what the DISSOLVE data show.
SGLT2 inhibitors lower blood sugar and uric acid. New 2026 research shows they may also reduce gout flares and the need for allopurinol.
New research from the AAOS 2026 meeting links GLP-1 drugs like Ozempic and Wegovy to a small but real increase in gout and osteoporosis risk. Here’s what the data actually shows, why it may happen, and what you can do about it.